Related Experiment Video
Updated: May 7, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Curcumin Alleviates Bone Cancer Pain by Inhibiting Satellite Glial Cell Activity via Janus Kinase 1/Signal Transducer
Xinchao Jiang1, Yi Song1, Mei Fang1
1Department of Pain Medicine, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu, People's Republic of China.
Abstract:
Curcumin is the main active component of Curcuma longa L and has anti-inflammatory, antitumor, and neuroprotective properties, making it a potential candidate for bone cancer pain management. Network pharmacology, molecular docking, and molecular dynamics simulations were used to screen and validate core therapeutic targets of curcumin in bone cancer pain. An in vivo mouse model of bone cancer pain was established via intrafemoral injection of Lewis lung cancer cells. A series of in vivo assays was conducted to evaluate pain sensitivity, bone microstructure, inflammatory cytokines, pain-related neuropeptides, and protein expression levels. In silico analysis verified that curcumin has a strong binding affinity for JAK1 and STAT3. In vivo results demonstrated that curcumin dose-dependently elevated the paw withdrawal threshold and latency, as well as ameliorated bone mineral density and bone destruction. Curcumin also suppressed pro-inflammatory cytokines, substance P, calcitonin gene-related peptides, and inhibited satellite glial cell activation by blocking the JAK1/STAT3 pathway. Notably, JAK1 agonist (RO8191) co-administration markedly reversed the analgesic effects of curcumin. Curcumin targets the JAK1/STAT3 signaling pathway, inhibits satellite glial cell activation, downregulates pro-inflammatory cytokine release, and pain-related neuropeptide expression. Therefore, curcumin exerted a significant analgesic effect against bone cancer pain. Elucidating the analgesic mechanism revealed the core therapeutic targets of curcumin in treating bone cancer pain. This study provides experimental evidence for further research on bone cancer pain.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The JAK-STAT Signaling Pathway
Blood and Nerve Supply to the Bones
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
